Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > Love the markets like this ...

<< Previous

Bullboard Posts

Next >>

Comment by Eoj123on Mar 23, 2023 3:23pm

91 Views

Post# 35357076

RE:Love the markets like this ...

MrMugsy wrote: It is in times like this, when panic fills the air (banking concerns), that I am most interested in what GUD might do strategically. No big risk, just a few add-ons.

We also have interest rates causing havoc because people just aren't ready for this. Excessive debt that isn't as easy to service.

This is where GUD can make some waves for the future - find some depressed assets - add on a few opportunities.

I'm not saying they will but this is where they can get the green light to buy some things.

Personally - I'd like to see a few depressed assets come our way over the 2023 year. Makes sense to pull the trigger. IMO.

This stock is a joke, and so are you promoters

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale